Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • 0,0 (0)
  • SCIENZE BIOLOGICHE
  • OGNI GIORNO

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

    3 H FA

    Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

    In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership changes continue at Sarepta Therapeutics and Rivus Pharmaceuticals, and Boehringer Ingelheim secures an exclusive license for a preclinical small-molecule program.

    2 min
  2. The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?

    3 H FA

    The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?

    The episode will explore structural implications for supply chains, distribution models, and international strategy, not a political discussion, but a forward-looking planning lens.

    10 min
  3. Pharmaceutical Executive Daily: FDA Approves Braftovi

    1 G FA

    Pharmaceutical Executive Daily: FDA Approves Braftovi

    In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk and GSK announce major deal activity in a mergers and acquisitions roundup, and UK regulators confiscate thousands of doses of illegal weight-loss medicines.

    2 min
  4. Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products

    2 GG FA

    Pharmaceutical Executive Daily: Novo Nordisk Announces Price Reductions for GLP-1 Products

    In today’s Pharmaceutical Executive Daily, AbbVie invests $380 million to expand API manufacturing capacity while Bora Pharmaceuticals and GSK enter a five-year manufacturing agreement, Novo Nordisk announces significant price reductions for its leading GLP-1 therapies, and Astellas enters a billion-dollar global collaboration with Vir Biotechnology to advance PSMA-targeting cancer treatments.

    2 min
  5. Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna

    6 GG FA

    Pharmaceutical Executive Daily: BioNTech Files Patent iInfringement Lawsuit Against Moderna

    In today’s Pharmaceutical Executive Daily, BioNTech files a patent infringement lawsuit against Moderna, the Supreme Court rules against a large number of Trump-era tariffs, and the FDA approves a Calquence–venetoclax combination for certain blood cancers.

    2 min
  6. Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

    19 FEB

    Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals

    In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billion agreement to acquire Eucalyptus, and experts examine how FDA can help ease early-stage clinical trial bottlenecks.

    2 min
  7. Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine

    18 FEB

    Pharmaceutical Executive Daily: FDA Initiates Review of Moderna’s Seasonal Influenza Vaccine

    In today’s Pharmaceutical Executive Daily, the FDA begins reviewing Moderna’s seasonal flu vaccine under a revised regulatory approach, Eli Lilly signs a $100 million licensing agreement with CSL for an anti- IL-6 monoclonal antibody., and Southern Florida emerges as a growing biotech hub.

    2 min
  8. Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro

    17 FEB

    Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro

    In today’s Pharmaceutical Executive Daily, the FDA approves a monthly dosing schedule for Rybrevant Faspro, HHS Secretary Robert F. Kennedy Jr. revises the agency’s leadership team, and industry expert Sandy Tammisetty discusses what it takes to deliver actual value in today’s pharmaceutical landscape.

    2 min
Elenco completo (297)

Descrizione

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

Informazioni

  • Creatore
    Pharmaceutical Executive Podcast
  • Anni di attività
    2018 - 2026
  • Puntate
    297
  • Classificazione
    Contenuti adatti a tutti
  • Sito web del podcast
    Pharmaceutical Executive

Potrebbero piacerti anche…